Pfizer Lobbies China's IP Office To Restore Viagra Patent

Law360, New York (September 20, 2004, 12:00 AM EDT) -- Pfizer Inc. has quietly been lobbying China's State Intellectual Property Office to restore the company's domestic-use patent for the erectile-dysfunction drug Viagra, according to a published report.

Pfizer is "hopeful and cautiously optimistic" that the agency will reconsider its July decision to overturn the Viagra patent before an October 5 deadline for filing a formal court appeal, the company's senior vice president for corporate affairs, Robert Mallet, told the Asian edition of the Wall Street Journal.

"We have filed papers with the agency to ask them...
To view the full article, register now.